| Authors: |
Salmon JM; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University and The Alfred Hospital, Melbourne, Australia., Todorovski I; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Stanley KL; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Bruedigam C; Cancer Program, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia., Kearney CJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Martelotto LG; Single Cell Innovation Lab, Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia., Rossello F; Single Cell Innovation Lab, Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.; University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia., Semple T; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Arnau GM; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Zethoven M; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Bots M; Laboratory of Clinical Chemistry, Academic Medical Center, University of Amsterdam, the Netherlands., Bjelosevic S; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Cluse LA; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Fraser PJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Litalien V; Australian Centre for Blood Diseases, Monash University and The Alfred Hospital, Melbourne, Australia., Vidacs E; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., McArthur K; Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Matthews AY; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Sciences, Monash University Clayton Victoria, Australia., Gressier E; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia., de Weerd NA; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Sciences, Monash University Clayton Victoria, Australia., Lichte J; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, Düsseldorf, Germany., Kelly MJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hogg SJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Hertzog PJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Sciences, Monash University Clayton Victoria, Australia., Kats LM; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Vervoort SJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., De Carvalho DD; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada., Scheu S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, Düsseldorf, Germany., Bedoui S; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia., Kile BT; Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia., Lane SW; Cancer Program, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia., Perkins AC; Australian Centre for Blood Diseases, Monash University and The Alfred Hospital, Melbourne, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University and The Alfred Hospital, Melbourne, Australia., Dominguez PM; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Johnstone RW; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. |
